Table of Contents Author Guidelines Submit a Manuscript
International Journal of Analytical Chemistry
Volume 2016, Article ID 9404068, 7 pages
http://dx.doi.org/10.1155/2016/9404068
Research Article

A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine

Incepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh

Received 16 May 2016; Revised 28 July 2016; Accepted 31 July 2016

Academic Editor: Frantisek Foret

Copyright © 2016 Imran Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Stephens, “Conquering the meningococcus,” FEMS Microbiology Reviews, vol. 31, no. 1, pp. 3–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Khatami and A. J. Pollard, “The epidemiology of meningococcal disease and the impact of vaccines,” Expert Review of Vaccines, vol. 9, no. 3, pp. 285–298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. N. E. Rosenstein, B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes, “Meningococcal disease,” The New England Journal of Medicine, vol. 344, no. 18, pp. 1378–1388, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Findlow, P. Balmer, D. Yero, O. Niebla, R. Pajón, and R. Borrow, “Neisseria vaccines 2007,” Expert Review of Vaccines, vol. 6, no. 4, pp. 485–489, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. S. Stephens, B. Greenwood, and P. Brandtzaeg, “Epidemic meningitis, meningococcaemia, and Neisseria meningitidis,” The Lancet, vol. 369, no. 9580, pp. 2196–2210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. L. H. Harrison, “Epidemiological profile of meningococcal disease in the United States,” Clinical Infectious Diseases, vol. 50, supplement 2, pp. S37–S44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Leimkugel, V. Racloz, D. S. L. Jacintho, and G. Pluschke, “Global review of meningococcal disease. A shifting etiology,” Journal of Bacterial Research, vol. 1, pp. 6–18, 2009. View at Google Scholar
  8. L. H. Harrison, K. A. Shutt, S. E. Schmink et al., “Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era-United States, 2000-2005,” The Journal of Infectious Diseases, vol. 201, no. 8, pp. 1208–1224, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Pace, “MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection,” Current Opinion in Molecular Therapeutics, vol. 11, no. 6, pp. 692–706, 2009. View at Google Scholar · View at Scopus
  10. B. Greenwood and L. Manson, “Meningococcal meningitis in Africa,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 4, pp. 341–353, 1999. View at Google Scholar
  11. J. R. Lingappa, A. M. Al-Rabeah, R. Hajjeh et al., “Serogroup W-135 meningococcal disease during the Hajj, 2000,” Emerging Infectious Diseases, vol. 9, no. 6, pp. 665–671, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M. I. Issack and C. Ragavoodoo, “Hajj-related Neisseria meningitidis serogroup W135 in Mauritius,” Emerging Infectious Diseases, vol. 8, no. 3, pp. 332–334, 2002. View at Google Scholar · View at Scopus
  13. S. J. M. Hahné, S. J. Gray, J.-F. Aguilera et al., “W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001,” The Lancet, vol. 359, no. 9306, pp. 582–583, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Bröker, S. Jacobsson, M. Kuusi et al., “Meningococcal serogroup Y emergence in Europe: update 2011,” Human Vaccines & Immunotherapeutics, vol. 8, no. 12, pp. 1907–1911, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Vyse, J. M. Wolter, J. Chen, T. Ng, and M. Soriano-Gabarro, “Meningococcal disease in Asia: an under-recognized public health burden,” Epidemiology and Infection, vol. 139, no. 7, pp. 967–985, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. E. S. Gurley, M. J. Hossain, S. P. Montgomery et al., “Etiologies of bacterial meningitis in Bangladesh: results from a hospital-based study,” The American Journal of Tropical Medicine and Hygiene, vol. 81, no. 3, pp. 475–483, 2009. View at Google Scholar · View at Scopus
  17. C. H. Rasul, F. Muhammad, M. J. Hossain, K. U. Ahmed, and M. Rahman, “Acute meningoencephalitis in hospitalised children in southern Bangladesh,” Malaysian Journal of Medical Sciences, vol. 19, no. 2, pp. 67–73, 2012. View at Google Scholar · View at Scopus
  18. H. J. Jennings, “Capsular polysaccharides as human vaccines,” Advances in Carbohydrate Chemistry and Biochemistry, vol. 41, pp. 155–208, 1983. View at Publisher · View at Google Scholar · View at Scopus
  19. Meningococcal Polysaccharide Vaccine, “PhEur monograph 0250,” http://www.newdruginfo.com/pharmacopeia/bp2003/British%20Pharmacopoeia%20Volume%20III%5CMonographs%5CImmunological%20Products%5CMeningococcal%20Polysaccharide%20Vaccine.htm.
  20. G. Clément, J. F. Dierick, C. Lenfant, and D. Giffroy, “Development and validation of a molecular size distribution method for polysaccharide vaccines,” Pharmeuropa Bio & Scientific Notes, vol. 2014, pp. 44–63, 2013. View at Google Scholar
  21. C. von Hunolstein, L. Parisi, and D. Bottaro, “Simple and rapid technique for monitoring the quality of meningococcal polysaccharides by high performance size-exclusion chromatography,” Journal of Biochemical and Biophysical Methods, vol. 56, no. 1–3, pp. 291–296, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Von Hunolstein, L. Parisi, and S. Recchia, “A routine high-performance size-exclusion chromatography to determine molecular size distribution of Haemophilus influenzae type b conjugate vaccines,” Vaccine, vol. 17, no. 2, pp. 118–125, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. A. P. Stanley, O. Walter, and A. O. Paul, Vaccines, chapter 21, Academic Press, New York, NY, USA, 6th edition, 2013.
  24. R. L. Synge, “Fractionation of hydrolysis products of amylose by electrokinetic ultrafiltration in an agar agar jelly,” Biochemical Journal, vol. 24, no. 2, pp. 41–42, 1950. View at Google Scholar
  25. M. Sadao and G. B. Howard, “Size exclusion chromatography,” in Springer Science & Business Media, pp. 1–5, Springer Laboratory, 1999. View at Google Scholar
  26. WHO Technical Report Series, “Requirement for meningococcal polysaccharide vaccine,,” Anex6, Requirement for Biological Substance No. 23, Addendum, 1980, http://www.who.int/biologicals/publications/trs/areas/vaccines/meningococcal/WHO_TRS_658_(part2)_MeningA6.pdf?ua=1.
  27. J. A. McCauley, R. J. Mancinelli, G. V. Downing, and J. B. Robbins, “Molecular size characterization of bacterial capsular polysaccharide vaccines with Sepharose® CL-2B,” Journal of Biological Standardization, vol. 9, no. 4, pp. 461–468, 1981. View at Publisher · View at Google Scholar · View at Scopus
  28. A. C. Rapraeger and M. Bernfield, “Heparan sulfate proteoglycans from mouse mammary epithelial cells. A putative membrane proteoglycan associates quantitatively with lipid vesicles,” The Journal of Biological Chemistry, vol. 258, no. 6, pp. 3632–3636, 1983. View at Google Scholar · View at Scopus
  29. A. Ogamo, T. Yamada, and K. Nagasawa, “A study on heterogeneity in molecular species of shark cartilage chondroitin sulfate C. Fractionation of the polysaccharide on sepharose CL-4B in the presence of high concentrations of ammonium sulfate,” Carbohydrate Research, vol. 165, no. 2, pp. 275–280, 1987. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Frosch and M. C. J. Maiden, Handbook of Meningococcal Disease: Infection Biology, Vaccination, Clinical Management, Wiley-VCH, New York, NY, USA, 2006. View at Publisher · View at Google Scholar
  31. G. K. Ackers, “Molecular exclusion and restricted diffusion processes in molecular-sieve chromatography,” Biochemistry, vol. 3, no. 5, pp. 723–730, 1964. View at Publisher · View at Google Scholar · View at Scopus
  32. R. M. Alsop and G. J. Vlachogiannis, “Determination of the molecular weight of clinical dextran by gel permeation chromatography on TSK PW type columns,” Journal of Chromatography A, vol. 246, no. 2, pp. 227–240, 1982. View at Publisher · View at Google Scholar · View at Scopus
  33. Q. P. Lei, A. G. Shannon, R. K. Heller, and D. H. Lamb, “Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines,” Developments in biologicals, vol. 103, pp. 259–264, 2000. View at Google Scholar · View at Scopus
  34. X. Lemercinier and C. Jones, “Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production,” Carbohydrate Research, vol. 296, pp. 83–96, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Ravenscroft, G. Averani, A. Bartoloni et al., “Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines,” Vaccine, vol. 17, no. 22, pp. 2802–2816, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Ho, X. Lemercinier, B. Bolgiano, D. Crane, and M. J. Corbel, “Solution stability studies of the subunit components of meningococcal C oligosaccharide-CRM197 conjugate vaccines,” Biotechnology and Applied Biochemistry, vol. 33, no. 2, pp. 91–98, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. M. M. Ho, B. Bolgiano, and M. J. Corbel, “Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines,” Vaccine, vol. 19, no. 7-8, pp. 716–725, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Arickx, “Analysis of a bivalent meningococcal vaccine (A+C),” Annales de la Societebelge de Medecinetropicale, vol. 59, pp. 259–266, 1979. View at Google Scholar
  39. J. Suker, I. M. Feavers, M. J. Corbel, C. Jones, and B. Bolgiano, “Control and lot release of meningococcal group C conjugate vaccines,” Expert Review of Vaccines, vol. 3, no. 5, pp. 533–540, 2004. View at Publisher · View at Google Scholar · View at Scopus